Abstract
This chapter will review the effects produced on neural development by maternal consumption of cannabinoids during gestation and lactation, with emphasis in thematuration of several neurotransmitter systems (dopamine, serotonin, opioids, cannabinoids, etc.) and possible modifications in their functional expression at the behavioral or neuroendocrine levels. In addition, we have analyzed the possible existence of a sexual dimorphism in these ontogenic effects of cannabinoids, as well as the possible molecular mechanism underlying such effects. In general, the results discussed support the view that exposure to cannabinoids during critical periods of development produces marked modifications in the functional expression of diverse neuronal systems in adulthood. Furthermore, the functions of endocannabinoids in the brain are large not only in adulthood, but also in the period of prenatal and postnatal development. Thus, endocannabinoids have been reported to be present in early ages and to play a role in the process of brain development: neural proliferation and migration, axonal elongation, synaptogenesis and/or myelogenesis.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
References
Araki W, Wurtman RJ (1997) Control of membrane phosphatidylcholine biosynthesis by diacylglycerol levels in neuronal cells undergoing neurite outgrowth. Proc Natl Acad Sci USA 94:11946–11950
Asch RH, Smith CG (1986) Effects of Δ9-THC, the principal psychoactive component of marihuana, during pregnancy in the rhesus monkey. J Reprod Med 31:1071–1081
Berrendero F, García-Gil L, Hernández ML, Romero J, Cebeira R, de Miguel R, Ramos JA, Fernández-Ruiz JJ (1998) Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptors in rat brain during fetal development. Development 125:3179–3188
Berrendero F, Sepe N, Ramos JA, Di Marzo V, Fernández-Ruiz JJ (1999) Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 33:181–191
Biegon A, Kerman IA (2001) Autoradiographic study of pre-and postnatal distribution of cannabinoids receptors in human brain. Neuroimage 14:1463–1468
Bonnin A, de Miguel R, Castro JG, Ramos JA, Fernández-Ruiz JJ (1996) Effects of perinatal exposure to Δ9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase containing neurons in rat brain. J Mol Neurosci 7:291–308
Burden-Galley SM, Pendergast M, Lemmon V (1997) The role of cell adhesion molecule L1 in axonal extension, growth cone motility, and signal transduction. Cell Tissue Res 290:415–422
Corchero J, Garcia-Gil L, Manzanares J, Fernández-Ruiz JJ, Fuentes JA, Ramos JA (1998) Perinatal Δ9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats. Life Sci 63:843–850
Dalterio SL (1980) Perinatal or adult exposure to cannabinoids alter male reproductive functions in mice. Pharmacol Biochem Behav 12:143–153
Dalterio SL (1986) Cannabinoid exposure: effects on development. Neurobehav Toxicol Teratol 8:345–352
Dalterio SL, Barker A (1979) Perinatal exposure to cannabinoids alter male reproductive functions in mice. Science 205:1420–1422
Del Olmo E, Pazos A (2001) Aminergic receptors during the development of the human brain: the contribution of in vitro imaging techniques. J Chem Neuroanat 22:101–114
Di Marzo V (1998) Endocannabinoids and others fatty acid derivatives with cannabimimetics properties: biochemistry and possible physiopathological relevance. Biochim Biophys Acta 1392:153–175
Fernández-Ruiz JJ, Rodriguez de Fonseca F, Navarro M, Ramos JA (1992) Maternal cannabinoid exposure and brain development: changes in the ontogeny of dopaminergic neurons. In: Bartke A, Murphy LL (eds) Neurobiology and neurophysiology of cannabinoids, biochemistry and physiology of substance abuse, vol IV. CRC Press, Boca Raton, pp 119–164
Fernández-Ruiz JJ, Bonnin A, Cebeira M, Ramos JA (1994) Ontogenic and adult changes in the activity of hypothalamic and extrahypothalamic dopaminergic neurons after perinatal cannabinoid exposure. In: Palomo T, Archer T (eds) Strategies for studying brain disorders, vol I. Farrand Press, London, pp 357–390
Fernández-Ruiz JJ, Romero J, García-Gil L, Garcia-Palomero E, Ramos JA (1996) Dopaminergic neurons as neurochemical substrates of neurobehavioral effects of marihuana: developmental and adult studies. In: Beninger RJ, Archer T, Palomo T (eds) Dopamine disease states. M Press, Madrid, pp 359–387
Fernández-Ruiz JJ, Muñoz RM, Romero J, Villanúa MA, Makriyannis A, Ramos JA (1997) Time-course of the effects of different cannabimimetics on prolactin and gonadotropin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. Biochem Pharmacol 53:1919–1927
Fernández-Ruiz JJ, Bonnin A, de Miguel R, Castro JG, Ramos JA (1998) Perinatal exposure to marihuana or its main psychoactive constituent, Δ9-tetrahydrocannabinol, affects the development of brain dopaminergic neurons. Arq Med 12:67–77
Fernández-Ruiz JJ, Berrendero F, Hernandez ML, Romero J, Ramos JA (1999) Role of endocannabinoids in brain development. Life Sci 65:725–736
Fernández-Ruiz JJ, Berrendero F, Hernandez ML, Ramos JA (2000) The endogenous cannabinoid system and brain development. Trends Neurosci 23:14–20
Fride E, Mechoulam R (1996a) Developmental aspects of anandamide: ontogeny of response and prenatal exposure. Psychoneuroendocrinology 21:157–172
Fride E, Mechoulam R (1996b) Ontogenic development of the response to anandamide and Δ9-tetrahydrocannabinol in mice. Brain Res Dev Brain Res 95:131–134
Fride E, Ginzburg Y, Breuer A, Bisogno T, Di Marzo V, Mechoulam R (2001) Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Eur J Pharmacol 419:207–214
Fried PA, Smith AM (2001) A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol 23:1–11
García-Gil L, de Miguel R, Ramos JA, Fernández-Ruiz JJ (1996) Perinatal Δ9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs. Drug Alcohol Depend 42:155–166
García-Gil L, Ramos JA, Rubino T, Parolaro D, Fernández-Ruiz JJ (1998) Perinatal Δ9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats. Neurotoxicol Teratol 20:549–553
García-Gil L, Romero J, Ramos JA, Fernández-Ruiz JJ (1999a) Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to Δ9-tetrahydrocannabinol. Drug Alcohol Depend 55:127–136
García-Gil L, de Miguel R, Romero J, Perez A, Ramos JA, Fernández-Ruiz JJ (1999b) Perinatal Δ9-tetrahydrocannabinol exposure augmented themagnitude of motor inhibition caused byGABA-B but notGABA-A, receptor agonists in adult rats. Neurotoxicol Teratol 21:277–283
Glass M, Dragunow M, Faull RLM (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299–318
Goldschmidt L, Day NL, Richardson GA (2000) Effects of prenatal marihuana exposure on child behavior problems at age 10. Neurobehav Toxicol 22:325–336
Gómez M, Hernández ML, Johansson B, de Miguel R, Ramos JA, Fernández-Ruiz J (2003) Prenatal cannabinoid exposure and gene expression for neural adhesion molecule L1 in the fetal rat brain. Brain Res Dev Brain Res 147:201–207
González B, de Miguel R, Martin S, Perez-Rosado A, Romero J, García-Lecumberri C, Fernández-Ruiz J, Ramos JA, Ambrosio E (2003) Effects of perinatal exposure to Δ9-tetrahydrocannabinol on operant morphine-reinforced behavior. Pharmacol Biochem Behav 75:577–584
Harbison RD, Mantilla-Plata B (1972) Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol. J Pharmacol Exp Ther 180:446–453
Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563–583
Hernández ML, García-Gil L, Berrendero F, Ramos JA, Fernández-Ruiz JJ (1997) Δ9-tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons. J Mol Neurosci 8:83–91
Hernández ML, Berrendero F, Suarez I, Garcia-Gil L, Cebeira M, Mackie K, Ramos JA, Fernández-Ruiz JJ (2000) Cannabinoids CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme. Brain Res 857:56–65
Insel TR (1995) The development of brain and behavior. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the four generation of progress. Raven Press, New York, pp 683–694
Kumar AM, Haney M, Becker T, Thompson ML, Kream RM, Miczek K (1990) Effect of early exposure to Δ9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropinreleasing hormone and substance P in the adult male rat brain. Brain Res 525:78–83
Mailleux P, Vanderhaeghen JJ (1992a) Location of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons. Neurosci Lett 148:173–176
Mailleux P, Vanderhaeghen JJ (1992b) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655–668
Mato S, Del Olmo E, Pazos A (2003) Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci 17:1747–1754
Mereu G, Fá M, Ferraro L, Cagiano R, Antonelli T, Tattoli M, Ghiglieri V, Tanganelli S, Gessa GL, Cuomo V (2003) Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci USA 100:4915–4920
Mokler DA, Robinson SE, Johnson JH, Hong JS, Rosecrana JA (1987) Neonatal administration of Δ9-tetrahydrocannabinol alters the neurochemical response to stress in the adult Fischer-344 rat. Neurotoxicol Teratol 9:321–326
Molina-Holgado F, Amaro A, Gonzalez I, Alvarez FJ, Leret ML (1996) Effects of maternal Δ9-tetrahydrocannabinol ondevelopingserotoninergic neurons. Eur J Pharmacol 316:39–42
Molina-Holgado F, Alvarez FJ, González I, Antonio MT, Leret ML (1997) Maternal exposure to Δ9-tetrahydrocannabinol (Δ9-THC) alters indolamine levels and turnover in adult male and female rat brain regions. Brain Res Bull 43:173–178
Murphy LL, Steger RW, Bartke A (1990) Psychoactive and non-psychoactive cannabinoids and their effects on reproductive neuroendocrine parameters. In: Watson RR (ed) Biochemistry and physiology of substance abuse, vol 2. CRC Press, Boca Raton, pp 73–94
Murphy LL, Gher J, Szary A (1995) Effects of prenatal exposure to Δ9-tetrahydrocannabinol on reproductive, endocrine and immune parameters of the male and the female rat offspring. Endocrine 3:875–881
Navarro M, Rodríguez de Fonseca F, Hernández ML, Ramos JA, Fernández-Ruiz JJ (1994) Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol Biochem Behav 47:47–58
Navarro M, de Miguel R, Rodríguez F, Ramos JA, Fernández JJ (1996) Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats. Brain Res Dev Brain Res 75:91–98
Pacheco MA, WardS SJ, Childers SR (1993) Identification of cannabinoids receptors in cultures of rat cerebellar granule cells. Brain Res 603:102–110
Panicker AK, Bulusi M, Theleu K, Maness PF (2003) Cellular signalling mechanisms of neural cell adhesion molecules. Front Biosci 8:900–911
Pares-Herbute N, Tapia-Arancibia L, Artier H (1989) Ontogeny of themetencephalic, mesencephalic and diencephalic content of catecholamines as measured by high performance liquid chromatography with electrochemical detection. Int J Dev Neurosci 7:73–79
Park B, Gibbons HM, Mitchell MD, Glass M (2003) Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH)in the human placenta. Placenta 24:990–995
Park B, McPartland JM, Glass M (2004) Cannabis, cannabinoids and reproduction. Prostaglandins Leukot Essent Fatty Acids 70:189–197
Pérez-Rosado A, Manzanares J, Fernández-Ruiz J, Ramos JA (2000) Prenatal Δ9-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences. Brain Res Dev Brain Res 120:77–81
Pérez-Rosado A, Gomez M, Manzanares J, Ramos JA, Fernández-Ruiz J (2002) Changes in prodynorphine and POMC gene expression in several brain regions of rat fetuses prenatally exposed to Δ9-tetrahydrocannabinol. Neurotox Res 4:211–218
Ramos JA, de Miguel R, Cebeira M, Hernández ML, Fernández-Ruiz J (2002) Exposure to cannabinoids in the development of endogenous cannabinoid system. Neurotox Res 4:363–372
Rodriguez de Fonseca F, Cebeira M, Fernández-Ruiz JJ, Navarro M, Ramos JA (1991) Effects of pre-andperinatal exposure to hashish extracts onthe ontogeny of brain dopaminergic neurons. Neuroscience 43:713–723
Romero J, García-Palomero E, Fernández-Ruiz JJ, Ramos JA (1996) Involvement of GABA-B receptors in the motor inhibition produced by agonists of brain cannabinoid receptors. Behav Pharmacol 7:299–302
Romero J, García-Palomero E, Berrendero F, García-Gil L, Hernández ML, Ramos JA, Fernández-Ruiz JJ (1997) Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse 26:317–323
Rubio P, Rodríguez de Fonseca F, Muñoz RM, Ariznavarreta C, Martin JL, Navarro M(1995) Long-term behavioral effects of perinatal exposure to Δ9-tetrahydrocannabinol in rats: possible role of pituitary-adrenal axis. Life Sci 56:2169–2176
Rubio P, Rodríguez de Fonseca F, Martin JL, del Arco I, Bartolomé S, Villanúa MA, Navarro M (1998) Maternal exposure to low doses ofΔ9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring. Pharmacol Biochem Behav 61:229–238
Rueda D, Navarro B, Martínez-Serrano A, Guzman M, Galve-Ropert I (2002) The endocannabinoid anandamide inhibits neural progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. J Biol Chem 277:46645–46650
Sillence DJ, Allan D (1998) Utilization of phosphatidylcholine and production of diacylglycerol as a consequence of sphingomyelin synthesis. Biochem J 331:251–256
Vela G, Fuentes JA, Bonnin A, Fernández-Ruiz JJ, Ruiz-Gayo M (1995) Perinatal exposure to Δ9-tetrahydrocannabinol (Δ9-THC) leads to changes in opioid-related behavioral patterns in rats. Brain Res 680:142–147
Vela G, Martin S, Garcia-Gil L, Crespo JA, Ruiz-Gayo M, Fernández-Ruiz JJ, Garcia Lecumberry C, Pelaprat D, Fuentes JA, Ramos JA, Ambrosio E (1998) Maternal exposure to Δ9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central µ-opioid receptors in adult offspring female rats. Brain Res 807:101–109
Walters DE, Carr LA (1988) Perinatal exposure to cannabinoids alters neurochemical development in the rat brain. Pharmacol Biochem Behav 29:213–216
Yang ZM, Paria BC, Dey SK (1996) Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development. Biol Reprod 55:756–761
Zhou D, Song ZH (2001) CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells. J Neurosci Res 65:346–353 Pharmacokinetics and Metabolism of the Plant Cannabinoids, Δ9-Tetrahydrocannabinol, Cannabidiol and Cannabinol
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag
About this chapter
Cite this chapter
Ramos, J.A., Gómez, M., de Miguel, R. (2005). Effects on Development. In: Pertwee, R.G. (eds) Cannabinoids. Handbook of Experimental Pharmacology, vol 168. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26573-2_22
Download citation
DOI: https://doi.org/10.1007/3-540-26573-2_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22565-2
Online ISBN: 978-3-540-26573-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)